Literature DB >> 7086699

Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies.

L C Woodson, J H Dunnette, R M Weinshilboum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7086699

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  20 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.

Authors:  T Dervieux; Y Médard; V Baudouin; A Maisin; D Zhang; F Broly; C Loirat; E Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

3.  Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

Authors:  Liewei Wang; Tien V Nguyen; Richard W McLaughlin; Laura A Sikkink; Marina Ramirez-Alvarado; Richard M Weinshilboum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 4.  Pharmacogenetics of cancer therapy: getting personal.

Authors:  E Y Krynetski; W E Evans
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

5.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

Authors:  D M Otterness; C L Szumlanski; T C Wood; R M Weinshilboum
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

6.  Peliosis hepatis induced by 6-thioguanine administration.

Authors:  D Larrey; E Fréneaux; A Berson; G Babany; C Degott; D Valla; D Pessayre; J P Benhamou
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 7.  Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.

Authors:  E Y Krynetski; W E Evans
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

8.  Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

Authors:  C L Szumlanski; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

9.  Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

Authors:  H L Tai; E Y Krynetski; C R Yates; T Loennechen; M Y Fessing; N F Krynetskaia; W E Evans
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

10.  Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population.

Authors:  M Tinel; A Berson; D Pessayre; P Letteron; M P Cattoni; Y Horsmans; D Larrey
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.